Facilitating the regulatory pathway of essential paediatric medicines and formulations is a key step to give access to these products as early as possible. WHO encourages international cooperation among regulatory authorities in all its forms, including convergence, harmonization, information- and work-sharing, reliance and recognition.

The Paediatric Regulatory Network  is a global paediatric working network providing a platform for exchange of regulatory information on paediatric medical products and to support the availability of quality-assured medical products for children through facilitation of communication, collaboration, training, and regulatory harmonization across the development, registration, marketing authorization and pharmacovigilance of paediatric medical products.

All regulatory authorities of WHO Member States are eligible to join the network and contribute to the discussions. The PRN is proposed as an effective and flexible forum for enabling dialogue and fostering development of international consensus on effective regulatory approaches for increasing the availability of paediatric medical products.